Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2016

Sep 19, 2016

29841_dirs_2016-09-19_60c9ff4e-d0c4-4f0b-95ea-30ec68312a33.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-09-15

Reporting Person: Powell Kendall J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-09-15 Ordinary Shares M 2977 $51.61 Acquired 27198 Direct
2016-09-15 Ordinary Shares M 1010 $52.84 Acquired 28208 Direct
2016-09-15 Ordinary Shares M 1590 $50.34 Acquired 29798 Direct
2016-09-15 Ordinary Shares M 2671 $29.96 Acquired 32469 Direct
2016-09-15 Ordinary Shares M 1813 $44.13 Acquired 34282 Direct
2016-09-15 Ordinary Shares S 7907 $85.445 Disposed 26375 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-09-15 Stock Option (Right to Buy) $51.61 M 2977 Disposed 2017-06-22 Ordinary Shares (2977) Direct
2016-09-15 Stock Option (Right to Buy) $52.84 M 1010 Disposed 2017-09-01 Ordinary Shares (1010) Direct
2016-09-15 Stock Option (Right to Buy) $50.34 M 1590 Disposed 2018-04-28 Ordinary Shares (1590) Direct
2016-09-15 Stock Option (Right to Buy) $29.96 M 2671 Disposed 2019-04-27 Ordinary Shares (2671) Direct
2016-09-15 Stock Option (Right to Buy) $44.13 M 1813 Disposed 2020-05-03 Ordinary Shares (1813) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 3000 Indirect

Footnotes

F1: This balance increased by 110 shares due to exempt transactions such as dividend reinvestment.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.433 to $85.453, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: This option to purchase 2,713 New Medtronic ordinary shares for $51.61 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,713 Medtronic common stock shares for $51.61 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 264 New Medtronic ordinary shares for $51.61 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 264 Medtronic common stock shares for $51.61 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F5: This option to purchase 1,010 New Medtronic ordinary shares for $52.84 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,010 Medtronic common stock shares for $52.84 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F6: This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F7: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F8: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.